Christian Dillon
Chief Scientific Officer PhoreMost
Seminars
Wednesday 11th March 2026
Discovering & Validating Novel E3 Ligases to Expand Degrader Utility & Achieve Proof-of-Concept Across Diverse Targets
1:30 pm
- Applying phenotypic and functional genomics screens to uncover novel E3 ligases with translational relevance
- Establishing mechanistic and in vivo validation to demonstrate degrader efficacy and tissue selectivity
- Exploring the potential for broad target applicability and therapeutic versatility of emerging ligase systems
New Data
Noval Ligase
